ArticleDrug design, development and therapy2024

In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer's Disease.

Shu-Tong Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.